Navigation Links
Genetics dominant risk factor in common cancers
Date:6/27/2014

A study of individuals who have been adopted has identified genetics as the dominant risk factor in 'familial' breast, prostate and colorectal cancers.

Researchers at the Centre for Primary Health Care Research at Lund University and Region Skne in Sweden have presented the new research findings based on studies of population registers.

"The results of our study do not mean that an individual's lifestyle is not important for the individual's risk of developing cancer, but it suggests that the risk for the three most common types of cancer is dependent to a greater extent on genetics", said Bengt Zller, a reader at Lund University who led the study.

The researchers studied adoptees born in Sweden in relation to both their biological parents and their adoptive parents. The Swedish multi-generation register and the cancer register were used to monitor 70 965 adopted men and women. They were all born between 1932 and 1969 and developed breast cancer, prostate cancer or colorectal cancer between the years 1958 and 2010. Using register studies, the researchers also looked at their adoptive and biological parents over the same period.

The risk of cancer in adoptees with at least one biological parent who had had the same cancer was 80� per cent higher for breast cancer, prostate cancer and colorectal cancer than for a control group without a biological parent with the same cancer. There was, however, no higher risk for individuals with adoptive parents affected by breast cancer, prostate cancer or colorectal cancer than for a control group. Individuals with a biological parent with cancer also developed the disease at a younger age than those without a biological parent with the same cancer. The age at which an individual developed cancer was not, however, affected by whether an adoptive parent had had the same cancer.

The results are an important indicator of the significance of hereditary factors for breast, prostate and colorectal cancer, according to Bengt Zller.

"The occurrence of breast cancer, prostate cancer and colorectal cancer in biological parents is an important risk factor that should be included in patients' medical history and examinations. It is therefore important that doctors ask about family history so that they can decide whether further tests are needed", said Bengt Zller.


'/>"/>

Contact: Bengt Zöller
bengt.zoller@med.lu.se
46-403-91954
Lund University
Source:Eurekalert

Related medicine news :

1. Could genetics help explain intellectual disability in children?
2. Zebrafish research meeting to highlight advances in genetics and developmental biology
3. New from Garland Science -- now available: Genetics and Genomics in Medicine
4. Vanderbilt study explores genetics behind Alzheimers resiliency
5. Genetics may explain high-functioning senior athletes with hip abnormalities
6. Penn study reveals genetics impact risk of early menopause among some female smokers
7. New project on psychiatric, neurologic, and behavioral genetics
8. The epigenetics of breast cancer family history
9. Wake Forest Baptist researchers study alcohol addiction using optogenetics
10. NPC and Beyond Genetics Supplements Announce Hosts for SHREDZ 2013 Tri-State Bodybuilding and Physique Championships
11. EpicGenetics, Inc., Developer of the First Blood Test for Fibromyalgia, Releases Fibromyalgia App
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... PHILADELPHIA (PRWEB) , ... July 24, 2017 , ... ... Health , two organizations that already work hand-in-hand on an Innovation Collaboration program, ... transform the access, quality, experience and cost of the care members and patients ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... (adipose) transfer systems announces the issuance of United States Patent Number 9,695,398 (the ... adipose filtration technology. The '398 and '324 patents cover methods and systems ...
(Date:7/24/2017)... ... 24, 2017 , ... The 2017 NCSL International Workshop & ... focuses on the new ISO/IEC 17025 standards. This marks the first time in ... calibration will be changed. , As an exhibitor, METTLER TOLEDO will showcase ...
(Date:7/24/2017)... ... July 24, 2017 , ... A ... focused on delivering end-to-end sleep health care at scale, indicates record-breaking adherence ... that adherence rates for positive airway pressure (PAP) therapy, the most widely utilized ...
(Date:7/24/2017)... Calif. (PRWEB) , ... July 24, 2017 , ... A ... from food addiction to sexual abuse, and how she has overcome them. “Forbidden Memories: ... instances in her life and how she has risen above. , In “Memories,” readers ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... York City-based market research firm Kalorama Information notes seven trends ... new products to new costs, to the threat of generic ... Potential Pipeline Disruptors . Among them are ... Age-Driven Growth - True Impact Moment Arriving   ... growing population and, to a more extreme extent, the aging ...
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology: